Trends in Lung Cancer Treatment Outcomes in Mersey Region
Author Information
Author(s): S.W. Watkin, G.K. Hayhurst, J.A. Green
Primary Institution: University of Liverpool
Hypothesis
The introduction of new diagnostic and therapeutic approaches will improve survival rates for lung cancer patients.
Conclusion
The study found significant improvements in lung cancer survival rates over the years, particularly with the use of combination chemotherapy and surgical resection.
Supporting Evidence
- 5-year survival rates improved from 12.5% to 17.5% over the study period.
- Median survival after surgery increased from 13 to 30 months.
- 2-year survival for small cell carcinoma patients receiving chemotherapy improved from 2.5% to 7.5%.
Takeaway
This study looked at how lung cancer treatment has changed over time and found that more people are living longer after treatment.
Methodology
The study analyzed data from the Mersey Regional Cancer Registry for lung cancer cases diagnosed between 1974 and 1986, focusing on treatment types and survival outcomes.
Potential Biases
Potential selection bias due to the exclusion of patients not receiving active treatment.
Limitations
The study may not account for all untreated patients and relies on historical data which could have inaccuracies.
Participant Demographics
The study included a diverse population from the Mersey Region, with a notable male:female ratio change from 3.59:1 to 2.02:1 over the study period.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website